Global Efficacy Testing Market Report 2022: Emerging Economies Providing Rapid Growth in End-Use Industries - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Efficacy Testing Market Research Report by Test Type (Antimicrobial/Preservative Efficacy Testing and Disinfectant Efficacy Testing), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Efficacy Testing Market size was estimated at USD 269.88 million in 2021, USD 287.53 million in 2022, and is projected to grow at a CAGR 6.71% to reach USD 398.64 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Efficacy Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Test Type, the market was studied across Antimicrobial/Preservative Efficacy Testing and Disinfectant Efficacy Testing. The Antimicrobial/Preservative Efficacy Testing is further studied across Rapid Test Method and Traditional Test Method. The Disinfectant Efficacy Testing is further studied across Surface Test Method and Suspension Test Method.
• Based on Application, the market was studied across Consumer Product Applications, Cosmetics & Personal Care Product Applications, Medical Device Applications, and Pharmaceutical Manufacturing Applications.
• Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Efficacy Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Market Dynamics

Drivers

• High focus on contamination control in products
• Increasing investments for the research and development activities in the pharmaceutical sector
• Growing applications of antimicrobial efficacy testing in various medical devices

Restraints

• High cost involved in different efficacy testing and trials

Opportunities

• Government policies and efforts towards new product safety and stability mainly in the pharma and medical sector
• Emerging economies providing rapid growth in end-use industries

Challenges

• Complex and time-consuming process

   

   

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Efficacy Testing Market, by Test Type

7. Efficacy Testing Market, by Application

8. Americas Efficacy Testing Market

9. Asia-Pacific Efficacy Testing Market

10. Europe, Middle East & Africa Efficacy Testing Market

11. Competitive Landscape

12. Company Usability Profiles

13. Appendix

Companies Mentioned

• 3M Group
• Abbott Analytical
• Accugen Laboratories, Inc.
• Betco
• Bioscience Laboratories, Inc.
• Blutest Laboratories Limited
• Cantel Medical Corporation
• Charles River Laboratories International, Inc.
• Diversey, Inc.
• Ecolab Inc.
• Eurofins Scientific
• Intertek Group PLC
• Medline Industries, Inc.
• Pacific Biolabs
• Reckitt Benckiser Group PLC
• SGS SA
• Steris PLC
• The Clorox Company
• The Procter & Gamble Company
• WuXi AppTec

For more information about this report visit https://www.researchandmarkets.com/r/vi2jka